Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Size Is Rewarded When Fostering Brand In India, But Pricing Has To Be Right: Elsevier Business Intelligence Webinar

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Becoming too big may have resulted in operational inefficiencies and deteriorating R&D output for global drug makers, but getting bigger may be a successful formula for branded generics businesses in emerging markets
Advertisement

Related Content

CASE STUDY: Can Novartis India Reboot Star Brand Voveran?
Emerging Markets Survey Shows Limited Premium For International Drug Brands-Credit Suisse
Closer Look: Sun-Ranbaxy A Powerhouse But Sales Culture A Dilemma?
IMS Health Splits Open India’s Skewed Health Care Market; Cities Over-served, Rural Areas Neglected
Abbott Plays On Diverse Offering As It Cruises Higher Than Most In India
Lupin Categorically Denies Sell-off Talks Amid Speculation Of $1 Billion Valuation For India Business
Merck Emerging Markets President Kevin Ali On The Branded Generics Business: An Interview With PharmAsia News (Part 2 of 2)
India's Sales Rankings Shuffle As IMS Health Widens Audit To Hospitals And Doctors
India's Sales Rankings Shuffle As IMS Health Widens Audit To Hospitals And Doctors
Piramal Deal Done, Abbott's India Plunge May Fetch Big Returns, But Integration Challenges, Growth Momentum Critical
Advertisement
UsernamePublicRestriction

Register

SC078340

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel